Considering that the expression of this inhibitory receptor on NK cells can compromise their anti-tumor activity, and that PF-derived primary cell lines express both PD-L1 and PD-L2 (Supplementary Figure 3), the increased PD-1 expression may play a role in inducing NK cell impairment in tumor control. Here, PDCD1LG2 is linked to neoplasm.